SAN FRANCISCO, CA --(Marketwired - July 20, 2016) - Under the guidance of newly appointed president Kenneth Efird, Nobilis Health Corp. plans to continue to roll out new products and optimize its marketing strategy.
Included in this article is: Nobilis Health Corp. (
Kenneth Efird will oversee Nobilis Health Corp.'s operating units across the nation, focusing on execution of the company's strategic plan, according to a press release issued on July 11. Prior to stepping in as president, Efird had served as chief operating officer and chief business development officer at Nobilis, which operates surgical hospitals, physician practices and ambulatory surgical centers in Texas and Phoenix.
Since coming on board in 2005, Efird has overseen various aspects of the company's business, including clinical operations, sales and "the rollout of a new marketing strategy, which includes the integration of Athas technologies and the expansion of Nobilis' portfolio of brands," according to the company.
Neil Maruoka, an analyst with Canaccord Genuity who initiated coverage on Nobilis on July 13, pointed out that Athas, the company's "marketing arm" is "a key differentiator and organic growth engine. . .Through its targeted marketing, we believe that Athas has the ability to drive higher case volumes and higher revenue per procedure through Nobilis' facilities."
Continue reading this article: Nobilis Moves Forward with New President and New Canaccord Coverage
About Streetwise Reports - The Life Sciences Report
The Life Sciences Report shares investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
DISCLOSURE:
The following companies mentioned in the article are sponsors of Streetwise Reports: Nobilis Health Corp. Streetwise Reports does not accept stock in exchange for its services. Comments and opinions expressed are those of the specific analysts and not of Streetwise Reports or its officers. The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.
The full disclosure is provided at the end of the published article: Nobilis Moves Forward with New President and New Canaccord Coverage
Jim Patrick Email contact
